Christopher Mehlin David - 31 May 2023 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role: COO & President, Director
Signature: /s/ Christopher David
Issuer symbol: NVOS
Transactions as of: 31 May 2023
Net transactions value: $0
Form type: 4
Filing time: 02 Jun 2023, 16:05:37 UTC
Next filing: 12 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NVOS	Class A Common Stock						81,950	31 May 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVOS	Stock Option (right to buy)	Award	$0	+2,000,000		$0.000000	2,000,000	31 May 2023	Common Stock	2,000,000	$0.1320	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant, by the issuer's Board of Directors, of an option to purchase 2,000,000 shares of the issuer's common stock at an exercise price of $0.132 per share. The option was fully vested and exercisable on the date of grant and expires on May 31, 2029.